drugset / Trial / NCT00974012
Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions
RandomizedCrossoverOpen-label
Summary
This study was designed to compare the relative bioavailability (rate and extent of absorption) of Divalproex Sodium ER Tablets 500 mg with that of Depakote® ER Tablets 500 mg following a single, oral dose (1 x 500 mg extended release tablet) administered to healthy, adult subjects under non-fasting conditions.
Timeline
- Start
- 2006-10
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Divalproex Sodium | Small molecule | 500 mg | Oral |
Indications
No indication recorded.